Abstract
Dual energy X-ray absorptiometry (DEXA) of the hip or spine has been shown to be an effective screening tool for osteoporosis in men undergoing androgen deprivation therapy (ADT) for advanced carcinoma of the prostate. A less expensive alternative to DEXA is the use of peripheral scanners, such as accuDEXA, which measures bone mineral density (BMD) the finger. In this paper, we reviewed 59 patients on ADT who underwent both accuDEXA scan of the non-dominant hand and DEXA scan of the hip. The mean T-scores calculated by the two techniques were similar; however, the individual T-scores correlated poorly with each other. We conclude that men who require ADT for prostate cancer should undergo standard DEXA of the hip for osteoporosis screening.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 4 print issues and online access
$259.00 per year
only $64.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ross RW, Small EJ . Osteoporosis in men treated with androgen deprivation therapy for prostate cancer. J Urol 2002; 167: 1952–1956.
Kanis JA . Osteoporosis III: diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002; 359: 1929–1936.
Michaeli DA, Mirshahi A, Singer J, Rapa F, Plass DB, Bouxsein M . A new X-ray based osteoporosis screening tool provides accurate and precise assessment of bone mineral content. J Clin Densitom 1998; 2: 23–30.
Fiter J, Nolla JM, Gomez-Vaquero C, Martinez-Aguila D, Valverde J, Roig-Escofet D . A comparative study of computed digital absorptiometry and conventional dual-energy X-ray absorptiometry in postmenopausal women. Osteoporo Int 2001; 12: 565–569.
Daniell HW . Osteoporosis after orchiectomy for prostate cancer. J Urol 1997; 157: 439–444.
McGrath SA, Diamond T . Osteoporosis as a complication of orchiectomy in 2 elderly men with prostatic cancer. J Urol 1995; 154: 535–536.
Oefelein MG, Resnick MI . The impact of osteoporosis in men treated for prostate cancer. Urol Clin N Am 2004; 31: 313–319.
Walsh PC, DeWeese TL, Eisenberger MA . A structured debate: immediate versus deferred androgen suppression in prostate cancer – evidence for deferred treatment. J Urol 2001; 166: 508–516.
Diamond TH, Higano CS, Smith MR, Guise TA, Singer FR . Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy. Cancer 2004; 100: 892–899.
Stein BS, Ashok S . Osteoporosis and the aging male. Med Health Rhode Island 2002; 85: 160–162.
Kanis JA, Gluer CC . Position paper: an update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporos Int 2000; 11: 192–202.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bae, D., Leocadio, D. & Stein, B. A comparison of dual energy X-ray absorptiometry of the hip and accuDEXA of the finger for the diagnosis of osteoporosis in men on androgen deprivation therapy for advanced prostate cancer. Prostate Cancer Prostatic Dis 10, 94–96 (2007). https://doi.org/10.1038/sj.pcan.4500913
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.pcan.4500913